Background/Aim: Pseudoexfoliation (PSX) syndrome is associated with blood flow disturbances; however, its exact effect on choroidal blood flow and thickness remains to be elucidated. This study compared subfoveal choroidal thickness in normal eyes and in eyes with PSX using enhanced depth imaging optical coherence tomography (EDI-OCT). Methods: This prospective, cross-sectional study included 35 eyes of 35 patients (20 males, 15 females) with unilateral or bilateral PSX and 26 eyes of 26 healthy volunteers (13 males, 13 females). Besides a comprehensive ocular and physical examination, all subjects underwent EDI-OCT examination using an Optovue RTVue OCT device (Optovue Inc., Fremont, Calif., USA). Results: The mean choroidal thickness (CT) and ocular perfusion pressure (OPP) were lower in the PSX group than in the healthy controls (249.4 ± 46.3 vs. 282.5 ± 55.8 µm, p = 0.014 and 40.7 ± 5.8 vs. 44.3 ± 4.3 mm Hg, p = 0.007, respectively). In addition, both systolic blood pressure and diastolic blood pressure measurements were lower among the PSX patients. However, no correlation was found between CT and OPP. Conclusion: The findings of this study suggest that PSX is associated with an overall thinning of the subfoveal choroid and a significant decrease in OPP. Future studies are warranted to further examine these relations.

1.
Prince AM, Streeten BW, Ritch R, et al: Preclinical diagnosis of pseudoexfoliation syndrome. Arch Ophthalmol 1987;105:1076-1082.
2.
Ocakoglu O, Koyluoglu N, Kayiran A, et al: Microvascular blood flow of the optic nerve head and peripapillary retina in unilateral exfoliation syndrome. Acta Ophthalmol Scand 2004;82:49-53.
3.
Khalil AK, Kubota T, Tawara A, et al: Early changes in iris blood vessels in exfoliation syndrome. Curr Eye Res 1998;17:1124-1134.
4.
Mitchell P, Wang JJ, Smith W: Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 1997;124:685-687.
5.
Repo LP, Suhonen MT, Terasvirta ME, et al: Color Doppler imaging of the ophthalmic artery blood flow spectra of patients who have had a transient ischemic attack. Correlations with generalized iris transluminance and pseudoexfoliation syndrome. Ophthalmology 1995;102:1199-1205.
6.
Takahashi K, Muraoka K, Kishi S, et al: Watershed zone in the human peripheral choroid. Ophthalmology 1996;103:336-342.
7.
Spaide RF, Koizumi H, Pozzoni MC: Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 2008;146:496-500.
8.
Margolis R, Spaide RF: A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 2009;147:811-815.
9.
Dadaci Z, Doganay F, Oncel Acir N, et al: Enhanced depth imaging optical coherence tomography of the choroid in migraine patients: implications for the association of migraine and glaucoma. Br J Ophthalmol 2014;98:972-975.
10.
Lee SH, Kim J, Chung H, et al: Changes of choroidal thickness after treatment for diabetic retinopathy. Curr Eye Res 2014;39:736-744.
11.
Anderson DR: Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma. Surv Ophthalmol 1999;43(suppl 1):S5-S9.
12.
Anderson DR, Davis EB: Glaucoma, capillaries and pericytes. 5. Preliminary evidence that carbon dioxide relaxes pericyte contractile tone. Ophthalmologica 1996;210:280-284.
13.
Branchini L, Regatieri CV, Flores-Moreno I, et al: Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. Ophthalmology 2012;119:119-123.
14.
Manjunath V, Taha M, Fujimoto JG, et al: Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol 2010;150:325-329.e1.
15.
Goktas S, Sakarya Y, Ozcimen M, et al: Choroidal thinning in pseudoexfoliation syndrome detected by enhanced depth imaging optical coherence tomography. Eur J Ophthalmol 2014;24:879-884.
16.
Cioffi GA, Granstam E, Alm A: Ocular circulation; in Kaufman PL, Alm A (eds): Adler's Physiology of the Eye: Clinical Application. St Louis, Mosby-Year Book, 2003, pp 780-784.
17.
Hayreh SS: Segmental nature of the choroidal vasculature. Br J Ophthalmol 1975;59:631-648.
18.
Riva CE, Titze P, Hero M, et al: Choroidal blood flow during isometric exercises. Invest Ophthalmol Vis Sci 1997;38:2338-2343.
19.
Riva CE, Titze P, Hero M, et al: Effect of acute decreases of perfusion pressure on choroidal blood flow in humans. Invest Ophthalmol Vis Sci 1997;38:1752-1760.
20.
Polska E, Simader C, Weigert G, et al: Regulation of choroidal blood flow during combined changes in intraocular pressure and arterial blood pressure. Invest Ophthalmol Vis Sci 2007;48:3768-3774.
21.
Kiel JW, van Heuven WA: Ocular perfusion pressure and choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci 1995;36:579-585.
22.
Gherghel D, Orgul S, Gugleta K, et al: Relationship between ocular perfusion pressure and retrobulbar blood flow in patients with glaucoma with progressive damage. Am J Ophthalmol 2000;130:597-605.
23.
Nickla DL, Wallman J: The multifunctional choroid. Prog Retin Eye Res 2010;29:144-168.
24.
Sibour G, Finazzo C, Boles Carenini A: Monolateral pseudoexfoliatio capsulae: a study of choroidal blood flow. Acta Ophthalmol Scand Suppl 1997;224:13-14.
25.
Yuksel N, Karabas VL, Arslan A, et al: Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology 2001;108:1043-1049.
26.
Detorakis ET, Achtaropoulos AK, Drakonaki EE, et al: Hemodynamic evaluation of the posterior ciliary circulation in exfoliation syndrome and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol 2007;245:516-521.
27.
Maul EA, Friedman DS, Chang DS, et al: Choroidal thickness measured by spectral domain optical coherence tomography: factors affecting thickness in glaucoma patients. Ophthalmology 2011;118:1571-1579.
28.
Kim M, Kim SS, Kwon HJ, et al: Association between choroidal thickness and ocular perfusion pressure in young, healthy subjects: enhanced depth imaging optical coherence tomography study. Invest Ophthalmol Vis Sci 2012;53:7710-7717.
29.
Schmidl D, Garhofer G, Schmetterer L: The complex interaction between ocular perfusion pressure and ocular blood flow - relevance for glaucoma. Exp Eye Res 2011;93:141-155.
30.
Simader C, Lung S, Weigert G, et al: Role of NO in the control of choroidal blood flow during a decrease in ocular perfusion pressure. Invest Ophthalmol Vis Sci 2009;50:372-377.
31.
Schmidl D, Weigert G, Dorner GT, et al: Role of adenosine in the control of choroidal blood flow during changes in ocular perfusion pressure. Invest Ophthalmol Vis Sci 2011;52:6035-6039.
32.
Fitzgerald ME, Wildsoet CF, Reiner A: Temporal relationship of choroidal blood flow and thickness changes during recovery from form deprivation myopia in chicks. Exp Eye Res 2002;74:561-570.
33.
Sogawa K, Nagaoka T, Takahashi A, et al: Relationship between choroidal thickness and choroidal circulation in healthy young subjects. Am J Ophthalmol 2012;153:1129-1132.e1.
34.
Vance SK, Imamura Y, Freund KB: The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina 2011;31:332-335.
35.
Tan CS, Ouyang Y, Ruiz H, et al: Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 2012;53:261-266.
36.
Li XQ, Larsen M, Munch IC: Subfoveal choroidal thickness in relation to sex and axial length in 93 Danish university students. Invest Ophthalmol Vis Sci 2011;52:8438-8441.
37.
Spaide RF: Age-related choroidal atrophy. Am J Ophthalmol 2009;147:801-810.
38.
Goldenberg D, Moisseiev E, Goldstein M, et al: Enhanced depth imaging optical coherence tomography: choroidal thickness and correlations with age, refractive error, and axial length. Ophthalmic Surg Lasers Imaging 2012;43:296-301.
39.
Brown JS, Flitcroft DI, Ying GS, et al: In vivo human choroidal thickness measurements: evidence for diurnal fluctuations. Invest Ophthalmol Vis Sci 2009;50:5-12.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.